Tandem Diabetes Care (NASDAQ:TNDM) Upgraded by Mizuho to Hold Rating
Mizuho upgraded shares of Tandem Diabetes Care (NASDAQ:TNDM – Free Report) to a hold rating in a research note issued to investors on Wednesday morning,Zacks.com reports. TNDM has been the subject of several other research reports. The Goldman Sachs Group decreased their target price on Tandem Diabetes Care from $42.00 to $24.00 and set a […]
Mizuho upgraded shares of Tandem Diabetes Care (NASDAQ:TNDM – Free Report) to a hold rating in a research note issued to investors on Wednesday morning,Zacks.com reports. TNDM has been the subject of several other research reports. The Goldman Sachs Group decreased their target price on Tandem Diabetes Care from $42.00 to $24.00 and set a […]
